patent/CH-611602-A5

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6fe9e449ae407658416f55e6e1a20db8
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-09
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-09
filingDate	1976-07-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce286082eeefb732ae506e7c106b567f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c23146048ff6bfcc5de2989479ee66bd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d6ff4e84aac7930850a5f426d0fecd17
publicationDate	1979-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	CH-611602-A5
titleOfInvention	Process for the preparation of (N-ethyl-2-pyrrolidino)methylamine derivatives
abstract	The compounds of formula: <IMAGE> in which R1 represents hydrogen or chlorine, are prepared by acylation of (N-ethyl-2-pyrrolidino)methylamine by means of an agent capable of giving up the group (C6H5)2C(R1)-CO-, for example an acid halide. The chlorine atom (R1) can then be replaced by a hydroxyl or alkoxy group. These compounds and their salts with acids can be used as medicaments for the treatment of cardiac rhythm disorders.
priorityDate	1975-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559516 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490133 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457192620 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6329

Total number of triples: 20.